Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
Nvidia Corp. NVDA, +4.69% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc....
Nvidia Corp. NVDA, +4.69% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc....
The Russell 2000 Index soared 12% in December, which might reflect investors’ exuberance about the state of the U.S. economy...
Shares of Enphase Energy Inc. fell again on Thursday after a longtime bullish analyst recommended investors stop buying, given the...
If you’re on Medicare and you’re going to be treated in a hospital, you might want to think twice before...
Losing weight is one of the top New Year’s resolutions that people make year after year, and with good reason....
Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission. The Irvine, Calif.-based...
Moderna Inc.’s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer upgraded the stock to the equivalent...
(Updated with Friday’s closing prices.) The U.S. stock market staged a remarkable rally in 2023, but 178 stocks in the...
The 2023 rally for stocks in the U.S. accelerated as more investors bought the idea that the Federal Reserve succeeded...
Investors have different approaches to stock dividends. Some have no interest in current income and would prefer companies to focus...